No Market Manipulation. The Company has not taken and will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act, Canadian Securities Laws or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Shares.
Appears in 4 contracts
Samples: Purchase Agreement (Oncolytics Biotech Inc), Purchase Agreement (Cardiome Pharma Corp), Purchase Agreement (Oncolytics Biotech Inc)
No Market Manipulation. The Company has not taken and will not taketaken, directly or indirectly, any action designed to cause or that would constitute which has constituted or that which might reasonably be expected to cause or result inresult, under the Exchange Act, Canadian Securities Laws Act or otherwise, in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common SharesSecurities.
Appears in 3 contracts
Samples: Exelon Corp, Exelon Corp, Underwriting Agreement (Exelon Corp)
No Market Manipulation. The Company has not taken and will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act, Canadian Securities Laws Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common SharesSecurities.
Appears in 2 contracts
No Market Manipulation. The Company has not taken and will not taketaken, directly or indirectly, any action designed to cause or that would constitute which has constituted or that which might reasonably be expected to cause or result inresult, under the Exchange Act, Canadian Securities Laws Act or otherwise, in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Shares.
Appears in 1 contract
Samples: Exelon Corp
No Market Manipulation. The Company has not taken and will not take, directly or indirectly, any action designed to or that would constitute or that might would reasonably be expected to cause or result in, under the Exchange Act, Canadian Securities Laws Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common SharesSecurities. 5.
Appears in 1 contract
Samples: Exelon Corp
No Market Manipulation. The Company has not taken and will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act, Canadian Securities Laws Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common SharesCorporate Units.
Appears in 1 contract
Samples: Exelon Corp
No Market Manipulation. The Company has not taken and will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act, Canadian Securities Laws Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Shares.
Appears in 1 contract
Samples: Exelon Corp